(Q38494430)

3 September 2017

0 references

1 reference

title

Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis (English)

1 reference

3 September 2017

1 reference

1 reference

1 reference

F Petrelli

1

1 reference

3 September 2017

E Pezzica

2

1 reference

3 September 2017

M Cabiddu

3

1 reference

3 September 2017

A Coinu

4

1 reference

3 September 2017

K Borgonovo

5

1 reference

3 September 2017

M Ghilardi

6

1 reference

3 September 2017

V Lonati

7

1 reference

3 September 2017

D Corti

8

1 reference

3 September 2017

S Barni

9

1 reference

3 September 2017

publication date

1 September 2015

1 reference

Journal of gastrointestinal cancer

3 September 2017

published in

1 reference

3 September 2017

volume

46

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

212-218

1 reference

Randomised trials of HIV prevention

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding as an index to identify high-risk patients with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Risk Factors of Nodal Involvement in T2 Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding and evidence-based treatment of T2 rectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Risk factors for an adverse outcome in early invasive colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

A new prognostic staging system for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding in colorectal carcinoma: time to take notice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-015-9716-1

Prognostic value of tumor "budding" in patients with colorectal cancer

21 January 2018

1 reference

12 December 2020

Budding as a useful prognostic marker in pT3 well‐ or moderately‐differentiated rectal adenocarcinoma

1 reference

12 December 2020

Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers

1 reference

12 December 2020

Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma

1 reference

12 December 2020

Tumour budding correlates with local recurrence of rectal cancer

1 reference

12 December 2020

Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding

1 reference

12 December 2020

Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma

1 reference

12 December 2020

The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer

1 reference

12 December 2020

Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection

1 reference

12 December 2020

Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer

1 reference

12 December 2020

Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer

1 reference

12 December 2020

Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer

1 reference

12 December 2020

Tumour budding as prognostic factor in stage I/II colorectal carcinoma

1 reference

12 December 2020

Pathological predictors for lymph node metastasis in T1 colorectal cancer

1 reference

12 December 2020

Tumour budding at invasive margins and outcome in colorectal cancer

1 reference

12 December 2020

Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status

1 reference

12 December 2020

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

12 December 2020

The role of tumour budding at the front of invasion and recurrence of rectal carcinoma

1 reference

12 December 2020

10.1007/S12029-015-9716-1

Identifiers

DOI

1 reference

3 September 2017

1 reference